Halozyme Therapeutics, Inc. today announced its wholly-owned subsidiary, Halozyme Hypercon, Inc., entered into a global exclusive collaboration and license agreement with Vertex Pharmaceuticals Incorporated ("Vertex"). Under the collaboration, Vertex has licensed Halozyme's Hypercon™ technology for use in up to three drug targets. Hypercon™ is an innovative microparticle technology that allows for hyperconcentration of drugs and biologics, thus reducing injection vol

Merck known as MSD outside of the United States and Canada, is commencing today, through a subsidiary, a cash tender offer to purchase all outstanding shares of common stock of Terns Pharmaceuticals, Inc. (“Terns”) (Nasdaq: TERN). On March 25, 2026, Merck announced that it had entered into a definitive agreement to acquire Terns. Upon the successful closing of the tender offer, stockholders of Terns will receive $53.00 net in cash for each share of Terns common stock val

The Pharma Partnering Summit (PPS US) 2026 is set to return to San Diego, California, on April 29–30, 2026, uniting senior business development and licensing (BD&L) professionals from the pharmaceutical and biotechnology sectors. This premier partnering forum provides an unrivaled platform for deal-making, strategic collaborations, and investment opportunities. Over two high-impact days, executives, investors, and innovators will engage in pre-arranged one-on-one meetings,

The Pharma Partnering EU Summit 2026 will take place in Basel, Switzerland, on May 20–21, 2026, bringing together global leaders in business development and licensing from pharmaceutical and biotech organizations. The summit provides a dynamic, partnership-focused environment for executives, innovators, and investors to explore licensing deals, co-development opportunities, joint ventures, and strategic alliances. With Basel’s reputation as a European pharmaceutical hub,

Thermo Fisher Scientific, the world leader in serving science, today introduces a next-generation cryogenic transmission electron microscope (cryo-TEM) designed to help scientists understand structural biology with greater clarity — now accessible in more lab environments than ever before. The Thermo Scientific™ Glacios™ 3 Cryo-TEM offers researchers the next major advancement in 200 kV imaging and structural analysis. Cryogenic electron microscopy (cryo-EM), an ad

Incheon, S. Korea and Maryland, United States, March 31, 2026 – Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company’s first manufacturing presence in the United States. The Rockville site comprises two cGMP manufacturing plants with a combined 60,000-liter drug substance capacity, sup

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlik

Shimadzu Scientific Instruments (SSI, Columbia, Maryland, USA), a Shimadzu Group company, has opened its new research and development (R&D) facility in South San Francisco, California. Since April 2024, SSI has been enhancing its R&D division with a focus on developing analytical instruments, software, applications, and lab automation solutions tailored to the needs of pharmaceutical and life science customers in North America. The San Francisco Bay Area is a premi

Bioptimus, a global AI company building the world's first world model for biology, today announced the launch of its Spatial Tissue Embedding Learning Atlas (STELA), a multinational spatial data generation initiative anchored by a partnership with 10x Genomics, Inc. (Nasdaq: TXG) and Broad Clinical Labs. While foundation models for language have thrived on vast digital datasets, biology has long lacked the standardized, high-quality data scale required for a similar breakthrough

UK Biotech Day 2026, taking place on 27–28 May 2026, will be held at the Radisson Hotel & Conference Centre London Heathrow. The event is set to spotlight the strength, global relevance, and collaborative spirit of the UK’s biotechnology ecosystem. It will bring together leaders from industry, research, government, and investment to share ideas, explore new opportunities, and shape the future of life sciences. UK Biotech Day is designed to spark meaningful conversati